Document:

EX-10.20

 Exhibit 10.20 

DERMTECH, INC. 

AMENDMENT NO. 1 TO 

SERIES C PREFERRED SECURITIES PURCHASE AGREEMENT 

This Amendment No. 1 (the “Amendment”) to that certain Series C Preferred Securities Purchase Agreement, dated as of
September 26, 2017 (the “Purchase Agreement”) is made and entered into effective as of March 5, 2018 (the “Effective Date”) by and among DermTech, Inc., a Delaware corporation (the
“Company”), and the persons and entities listed on the Schedule of Purchasers attached as Exhibit A thereto (the “Purchasers”). Capitalized terms used in this Amendment that are not otherwise defined herein
shall have the respective meanings assigned to them in the Purchase Agreement. 
 RECITALS 

WHEREAS, the Company previously authorized the sale and issuance of up to $15,500,000 of Series C Preferred Stock of the Company (the
“Series C Preferred Stock”) pursuant to the terms of the Purchase Agreement; 
 WHEREAS, the Company and the
Purchasers now desire to amend the terms of the Purchase Agreement as set forth below; 
 WHEREAS, pursuant to Section 6.10 of
the Purchase Agreement, any term of the Purchase Agreement may be amended by a written consent of the Company and the Purchases holding a majority of the Common Stock issued or issuable upon conversion of the Series C Preferred Stock issued pursuant
to the Purchase Agreement; and 
 WHEREAS, the undersigned constitute the Company and the Purchasers holding a majority of the Common
Stock issued or issuable upon conversion of the Series C Preferred Stock issued pursuant to the Purchase Agreement. 
 NOW,
THEREFORE, in consideration of these premises and the mutual covenants, terms and conditions set forth herein, all of the parties hereto mutually agree as follows: 

AGREEMENT 

1.    Amendment to Section 1.4 of the Purchase Agreement. Section 1.4 of the Purchase
Agreement is hereby amended and restated in its entirety as follows: 
 “Second Tranche
Investment. In addition to the Stock and Common Warrants purchased by RTW (defined below) in the First Subsequent Closing and the approximately $1,499,999 of additional Stock and Common Warrants purchased by RTW in the Closing occurring
on or around March 6, 2018, RTW Master Fund, LTD and RTW Innovation Master Fund, LTD (collectively, “RTW”) shall have the right, in their discretion, to purchase up to an aggregate of 270,758 additional shares of Stock (subject
to appropriate adjustment in the event of any stock dividend, stock split, combination or similar recapitalization affecting such shares) (the “Second Tranche Investment”) on or before September 15, 2018 (the “Second
Tranche Closing”) for an aggregate purchase price of $1,499,999.32 (such shares, “Second Tranche Investment Amount”). RTW shall have the right to allocate the Second Tranche Investment between its affiliated venture

 
funds so long as such fund(s) execute this Agreement and become bound by the terms and conditions set forth herein. For purposes of clarity, RTW will have no obligation to make the Second Tranche
Investment if there has been any Material Adverse Event (as defined below) after the First Subsequent Closing and such Material Adverse Event is still in effect and has not been cured, as determined by RTW in their discretion. As used herein,
“Material Adverse Event” shall mean, with respect to the Company, any change or effect that, when taken individually or together with all other changes or effects, is or could reasonably be expected to be materially adverse to the
business, operations, assets (intangible and otherwise) of the Company taken as a whole. RTW’s rights to consummate the Second Tranche Investment shall terminate and the Company shall have no further obligation to sell any additional shares of
Stock to RTW pursuant to this Section 1.4 upon the earlier to occur of (i) the Company’s sale of shares of its capital stock in a firm commitment underwritten public offering pursuant to a registration statement under the Securities
Act, (ii) a Liquidation Transaction as defined in Article IV Section (B)2(c)(i) of the Restated Certificate, as may be amended from time to time, or (iii) September 15, 2018. Notwithstanding anything to the contrary in this
Agreement, RTW hereby agree that RTW’s right to consummate the Second Tranche Investment and purchase shares of Stock pursuant to this Section 1.4 shall not be assignable except to an affiliate or limited partner of RTW, and any attempted
assignment by RTW shall be void.” 
 2.    Governing Law. This Amendment shall be governed in all respects
by the internal laws of the State of Delaware, without regard to principles of conflicts of law provisions of the State of Delaware or any other state. 

3.    Purchase Agreement. Wherever necessary, all other terms of the Purchase Agreement are hereby amended to be
consistent with the terms of this Amendment. Except as specifically set forth herein, the Purchase Agreement shall remain in full force and effect. 

4.    Counterparts; Facsimile. This Amendment may be executed in any number of counterparts, each of which shall be
an original, and all of which together shall constitute one instrument. Executed signatures transmitted via facsimile will be accepted and considered duly executed. 

[Remainder of page intentionally left blank] 

  
 -2- 

 IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No. 1
to Series C Preferred Securities Purchase Agreement as of the Effective Date. 
  

			
	COMPANY:
	
	DERMTECH, INC.,
	a Delaware corporation
		
	By:	 	 /s/ John Dobak

	Name:	 	John Dobak
	Title:	 	Chief Executive Officer

  

			
	Address:  	 	 11099 N. Torrey Pines Road
 Suite
100

		 	La Jolla, California 92037

 IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No. 1
to Series C Preferred Securities Purchase Agreement as of the Effective Date. 
  

			
	PURCHASER:
	
	Paulson DermTech Investments III LLC
		
	By:	 	 /s/ Starla Goff

	Name: Starla Goff
	Title: Officer of the Managing Member

 IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No. 1
to Series C Preferred Securities Purchase Agreement as of the Effective Date. 
  

			
	PURCHASER:
	
	Irwin and Joan Jacobs Family Trust 6-2-80
		
	By:	 	 /s/ Irwin M. Jacobs

	Name: Irwin M. Jacobs
	Title: Trustee

 IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No. 1
to Series C Preferred Securities Purchase Agreement as of the Effective Date. 
  

			
	PURCHASER:
	
	RTW Master Fund, LTD
		
	By:	 	 /s/ Roderick Wong

	Name: Roderick Wong
	Title: Director
	
	RTW Innovation Master Fund, LTD
		
	By:	 	 /s/ Roderick Wong

	Name: Roderick Wong
	Title: Director

 IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No. 1
to Series C Preferred Securities Purchase Agreement as of the Effective Date. 
  

	
	PURCHASER:
	
	/s/ Gene Salkind, M.D.
	Gene Salkind, M.D.

 IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No. 1
to Series C Preferred Securities Purchase Agreement as of the Effective Date. 
  

			
	PURCHASER:
	
	 /s/ Elliot Feuerstein

	Elliot Feuerstein
	
	Brett Feuerstein Children’s Trust
		
	By:	 	 /s/ Elliot Feuerstein

	Name: Elliot Feuerstein
	Title: Trustee
	
	Michael Feuerstein Children’s Trust
		
	By:	 	 /s/ Elliot Feuerstein

	Name: Elliot Feuerstein
	Title: Trustee
	
	Elliot Feuerstein Trust DTD 5-14-83
		
	By:	 	 /s/ Elliot Feuerstein

	Name: Elliot Feuerstein
	Title: Trustee
	
	Mesa Shopping Center East LLC
		
	By:	 	 /s/ Elliot Feuerstein

	Name: Elliot Feuerstein
	Title: Manager
	
	Mesa Shopping Center East LLC
		
	By:	 	 /s/ Elliot Feuerstein

	Name: Elliot Feuerstein
	Title: Manager
	
	Mira Mesa Shopping Center West LLC
		
	By:	 	 /s/ Elliot Feuerstein

	Name: Elliot Feuerstein
	Title: Manager
	
	Mira Mesa Shopping Center LLC
		
	By:	 	 /s/ Elliot Feuerstein

	Name: Elliot Feuerstein
	Title: ManagerEX-10.21

 Exhibit 10.21 

DERMTECH, INC. 
 AMENDED
AND RESTATED 
 INVESTORS’ RIGHTS AGREEMENT 

September 26, 2017 

 DERMTECH, INC. 

AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 

This Amended and Restated Investors’ Rights Agreement (the “Agreement”) is made as of September 26, 2017, by and
among DermTech, Inc., a Delaware corporation (the “Company”), the holders of the Company’s Common Stock set forth on Exhibit A-1 attached hereto (the “Common
Holders”), the Existing Investors (as defined below) set forth on Exhibit A-2 attached hereto, and the holders of Series C Preferred Stock listed on Exhibit
A-3 attached hereto (the “Preferred Holders,” and together with the Common Holders, and the Existing Investors, the “Investors”). 

RECITALS 

WHEREAS, certain of the Investors are parties to the Amended and Restated Series C Preferred Securities Purchase Agreement of even
date herewith, between the Company and the Investors listed on the Schedule of Purchasers attached as Exhibit A thereto (the “Purchase Agreement”), and it is a condition to the closing of the sale of the Series C Preferred
Stock to the Investors listed on such Schedule of Purchasers that the Common Holders, the Existing Investors, the Preferred Holders and the Company execute and deliver this Agreement; 

WHEREAS, certain of the Investors hold shares of the Series C Preferred Stock and/or shares of the Common Stock issued upon conversion
of the Company’s Series A and Series B Preferred Stock (the “Existing Investors”) and possess certain registration rights, information rights, rights of first refusal and other rights pursuant to the Amended and Restated
Investors’ Rights Agreement dated as of October 7, 2016 between the Company, such Existing Investors and the Common Holders (the “Prior Rights Agreement”); 

WHEREAS, the Existing Investors desire to terminate the Prior Rights Agreement and further desire that this Agreement supersede and
replace the Prior Rights Agreement in its entirety; 
 WHEREAS, pursuant to the terms of the Prior Rights Agreement, the Prior Rights
Agreement may be amended by the written consent of (i) the Company and (ii) holders of a majority of the Registrable Securities (as defined in the Prior Rights Agreement) then outstanding; and 

WHEREAS, the undersigned Investors represent the holders of a majority of the Registrable Securities. 

NOW, THEREFORE, in consideration of the mutual promises and covenants herein contained, and other consideration, the receipt and
adequacy of which is hereby acknowledged, the parties hereto agree as follows: 

  
 1 

 AGREEMENT 

1.    Registration Rights. The Company and the Investors covenant and agree as follows: 

1.1    Definitions. For purposes of this Section 1: 

(a)    “Affiliated Fund” means, with respect to a Holder that is a limited liability company or a
limited liability partnership, a fund or entity managed by the same manager or managing member or general partner or management company or by an entity controlling, controlled by, or under common control with such manager or managing member or
general partner or management company; 
 (b)    “Exchange Act” means the Securities Exchange Act of
1934, as amended (and any successor thereto) and the rules and regulations promulgated thereunder; 

(c)    “Excluded Registration” means (i) a registration statement relating solely to the sale of
securities of participants in a Company stock plan, (ii) a registration relating to a corporate reorganization or transaction under Rule 145 of the Securities Act, (iii) a registration relating solely to the offer and sale of debt
securities, or (iv) a registration on any registration form that does not permit secondary sales. 

(d)    “Form S-3” means such form
under the Securities Act as in effect on the date hereof or any successor form under the Securities Act that permits significant incorporation by reference of the Company’s subsequent public filings under the Exchange Act; 

(e)    “Holder” means any Investor owning or having the right to acquire Registrable Securities or any
assignee thereof in accordance with Section 1.12 of this Agreement; 
 (f)    “Investor
Securities” means (i) the Common Stock issuable or issued upon conversion of the Preferred Stock held by the Preferred Holders (and any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right, or other
security that is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, such shares), (ii) the Common Stock issued upon conversion of the Series A Preferred Stock and Series B Preferred Stock held by
the Existing Investors (and any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right, or other security that is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement
of, such shares), and (iii) the Common Stock held by the Common Holders (and any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right, or other security that is issued as) a dividend or other distribution
with respect to, or in exchange for or in replacement of, such shares); excluding, however, in all cases (a) any Investor Securities sold in a transaction in which the rights under this Agreement are not assigned, and (b) any
shares for which registration rights have terminated pursuant to Section 1.15 of this Agreement. 

(g)    “Major Investor” means (i) any Preferred Holder that holds at least 50,000 shares of the
Series C Preferred Stock (subject to adjustment for stock splits, stock dividends, combinations, reclassifications or the like), (ii) any Existing Investor that holds at least 3,000 shares of the Covered Securities (as defined below) (subject to
adjustment for stock 

  
 2 

 
splits, stock dividends, combinations, reclassifications or the like), and (iii) any Common Holder that holds at least 3,968 shares of the Covered Securities (subject to adjustment for stock
splits, stock dividends, combinations, reclassifications or the like). A Major Investor includes any general partners, managing members and affiliates of a Major Investor, including Affiliated Funds. Notwithstanding the foregoing, each of RTW Master
Fund, LTD and RTW Innovation Master Fund, LTD (together, “RTW”) will be deemed to be Major Investors so long as they hold at least 50,000 shares of the Series C Preferred Stock in the aggregate; 

(h)    “Preferred Stock” shall mean the Series C Preferred Stock. 

(i)    “Register,” “registered,” and “registration” refer to a
registration effected by preparing and filing a registration statement or similar document in compliance with the Securities Act, and the declaration or ordering of effectiveness of such registration statement or document; 

(j)    “Registrable Securities” means (i) the shares of Common Stock issuable or issued upon
conversion of the Preferred Stock held by the Holders and any assignee thereof in accordance with Section 1.12 of this Agreement, (ii) the shares of Common Stock issued upon conversion of the Series A Preferred Stock and Series B Preferred
Stock held by the Existing Investors and any assignee thereof in accordance with Section 1.12 of this Agreement, and (iii) any other shares of Common Stock of the Company issued as (or issuable upon the conversion or exercise of any
warrant, right or other security which is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, the shares listed in (i); excluding, however, in all cases (a) any Registrable
Securities sold in a transaction in which the rights under this Agreement are not assigned, (b) any shares for which registration rights have terminated pursuant to Section 1.15 of this Agreement. 

(k)    The number of shares of “Registrable Securities then outstanding” shall be determined by the
number of shares of Common Stock outstanding which are, and the number of shares of Common Stock issuable pursuant to then exercisable or convertible securities which are, Registrable Securities; 

(l)    “Restated Certificate” means the Company’s Amended and Restated Certificate of
Incorporation, as such may be amended from time to time. 
 (m)    “SEC” means the Securities and
Exchange Commission; and 
 (n)    “Securities Act” means the Securities Act of 1933, as amended (and
any successor thereto) and the rules and regulations promulgated thereunder 

(o)    “Series A Preferred Stock” shall mean the Company’s former Series A-1 Preferred Stock, former Series A-2 Preferred Stock, and former Series A-3 Preferred Stock. 

(p)    “Series B Preferred Stock” shall mean the Company’s former Series B
Preferred Stock. 

  
 3 

 (q)    “Series C Preferred Stock”
shall mean the Company’s Series C Preferred Stock. 
 1.2    Request for Registration. 

(a)    If the Company shall receive at any time after the earlier of (i) three (3) years after the Initial
Closing (as defined in the Purchase Agreement), or (ii) one hundred eighty (180) days after the effective date of the initial public offering, a written request from the Holders of a majority of the Registrable Securities
then outstanding (the “Initiating Holders”) that the Company file a registration statement under the Securities Act covering the registration of Registrable Securities with an anticipated aggregate offering price of at least
$10,000,000, then the Company shall, within 20 days after receiving such request, give written notice of such request to all Holders and shall, subject to the limitations of subsection 1.2(b), use commercially reasonable efforts to cause to be
registered under the Securities Act all of the Registrable Securities that each such Holder has requested to be registered within twenty (20) days after the mailing of such notice by the Company. 

(b)    If the Initiating Holders intend to distribute the Registrable Securities covered by their request by means of an
underwriting, they shall so advise the Company as a part of their request and the Company shall include such information in the written notice referred to in subsection 1.2(a). The underwriter will be selected by the Company, which underwriter
shall be reasonably acceptable to a majority in interest of the Holders whose Registrable Securities are to be included in the underwriting. In such event, the right of any Holder to include his Registrable Securities in such registration shall be
conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting (unless otherwise mutually agreed by a majority in interest of the Initiating Holders and such
Holder) to the extent provided herein. The Company and all Holders proposing to distribute their securities through such underwriting shall enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such
underwriting. Notwithstanding any other provision of this Section 1.2, if the underwriter advises the Company in good faith that marketing factors require a limitation of the number of shares to be underwritten, then the Company shall so advise
all Holders of Registrable Securities which would otherwise be underwritten pursuant hereto, and the number of shares of Registrable Securities that may be included in the underwriting shall be allocated among all participating Holders thereof,
including the Initiating Holders, in proportion (as nearly as practicable) to the amount of Registrable Securities of the Company owned by each participating Holder. In no event shall any Registrable Securities be excluded from such underwriting
unless all other securities are first excluded from such offering. Any Registrable Securities excluded from or withdrawn from such underwriting shall be withdrawn from registration. 

(c)    Notwithstanding the foregoing, if the Company shall furnish to the Initiating Holders a certificate signed by the
President of the Company stating that in the good faith judgment of the Board of Directors of the Company it would be seriously detrimental to the Company and its stockholders for such registration statement to be filed, the Company shall have the
right to defer such filing for a period of not more than 45 days after receipt of the request of the Initiating Holders; provided, however, that the Company may not utilize this right or the similar right set forth in
Section 1.4(b)(iii) more than twice in any 12-month period, and 

  
 4 

 
provided, further, that the Company shall not register any securities for the account of itself or any other stockholder during such 45-day
period (other than in an initial public offering or an Excluded Registration). 
 (d)    In addition, the Company shall
not be obligated to effect, or to take any action to effect, any registration pursuant to this Section 1.2: 

a)    After the Company has effected two (2) registrations pursuant to this Section 1.2 provided,
however, that such registrations have been declared or ordered effective and that either (A) the conditions of Section 1.5(a) have been satisfied or (B) the registration statements remain effective and there are no stop orders
in effect to such registration statements; 
 b)    During the period starting with the date 90 days prior to the
Company’s good faith estimate of the date of filing of, and ending on a date 180 days after the effective date of, a registration subject to Section 1.3 hereof unless such offering is not the initial public offering of the Company’s
securities, in which case, ending on a date 90 days after the effective date of such registration subject to Section 1.3 hereof; provided that the Company is actively employing in good faith commercially reasonable efforts to cause such
registration statement to become effective; or 
 c)    If the Initiating Holders propose to dispose of shares of
Registrable Securities that may be immediately registered on Form S-3 pursuant to a request made pursuant to Section 1.4 below. 

1.3    Company Registration. 

(a)    If (but without any obligation to do so) the Company proposes to register (including for this purpose a
registration effected by the Company for stockholders other than the Holders) any of its stock under the Securities Act in connection with the public offering of such securities solely for cash (other than an Excluded Registration), the Company
shall, at such time, promptly give each Investor written notice of such registration. Upon the written request of each Investor given within 20 days after mailing of such notice by the Company in accordance with Section 3.4, the Company shall,
subject to the provisions of Section 1.8, use commercially reasonable efforts to cause to be registered under the Securities Act all of the Investor Securities that each such Investor has requested to be registered if any stock of the Company
is registered. 
 (b)    The Company shall have the right to terminate or withdraw any registration initiated by it
under this Section 1.3 prior to the effectiveness of such registration whether or not any Investor has elected to include securities in such registration. The expenses of such registration shall be borne by the Company, in accordance with
Section 1.7 hereof. 
 1.4    Form S-3 Registration.
In case the Company shall receive from any Holder or Holders of the Registrable Securities then outstanding a written request or requests that the Company effect a registration on Form S-3 and any related
qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder or Holders, the Company will: 

  
 5 

 (a)    promptly give written notice of the proposed registration, and
any related qualification or compliance, to all other Holders; and 
 (b)    use commercially reasonable efforts to
effect, as soon as practicable, such registration and all such qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution of all or such portion of such Holder’s or Holders’
Registrable Securities as are specified in such request, together with all or such portion of the Registrable Securities of any other Holder or Holders joining in such request as are specified in a written request given within 15 days after receipt
of such written notice from the Company; provided, however, that the Company shall not be obligated to effect any such registration, qualification or compliance, pursuant to this Section 1.4: (i) if Form S-3 is not available for such offering by the Holders; (ii) if the Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration, propose to sell
Registrable Securities and such other securities (if any) at an aggregate price to the public of less than $1,000,000; (iii) after the Company has effected one (1) registration pursuant to this Section 1.4 during the immediately preceding
twelve (12) month period, provided, however, that such registration has been declared or ordered effective and that either (A) the conditions of Section 1.5(a) have been satisfied or (B) the registration statements
remain effective and there are no stop orders in effect to such registration statements has registered; (iv) if the Company shall furnish to the Holders a certificate signed by the President of the Company stating that in the good faith
judgment of the Board of Directors of the Company, it would be seriously detrimental to the Company and its stockholders for such registration statement to be filed, the Company shall have the right to defer such filing for a period of not more than
45 days after receipt of the request of the Holder or Holders under this Section 1.4; provided, however, that the Company shall not utilize this right or the similar right set forth in Section 1.2(c) more than once in any 12-month period, and provided, further, that the Company shall not register any securities for the account of itself or any other stockholder during such 45-day
period (other than an Excluded Registration); (v) in any jurisdiction in which the Company would be required to qualify to do business or to execute a general consent to service of process in effecting such registration, qualification or
compliance unless the Company is already qualified to do business or subject to service of process in that jurisdiction; or (vi) during the period ending 180 days after the effective date of a registration statement subject to Section 1.3.

 (c)    Subject to the foregoing, the Company shall file a registration statement covering the Registrable Securities
and other securities so requested to be registered as soon as practicable after receipt of the request or requests of the Holders. Registrations effected pursuant to this Section 1.4 shall not be counted as demands for registration or
registrations effected pursuant to Sections 1.2 or 1.3, respectively. 
 1.5    Obligations of the Company.
Whenever required under this Section 1 to effect the registration of any Registrable Securities or Investor Securities (any such securities required to be registered, the “Covered Securities”), the Company shall, as
expeditiously as reasonably possible: 
 (a)    Prepare and file with the SEC a registration statement with respect to
such Covered Securities and use commercially reasonable efforts to cause such registration statement to become effective, and, upon the request of the Holders of a majority of the 

  
 6 

 
Registrable Securities registered thereunder (or, if there are no Registrable Securities registered thereunder, upon the request of the Investors of a majority of the Investor Securities
registered thereunder), keep such registration statement effective for up to 120 days, or until the distribution described in such registration statement is completed, if earlier. 

(b)    Prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus
used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement for up to 120 days, or until the
distribution described in such registration statement is completed, if earlier. 
 (c)    Promptly notify the selling
Investors of the effectiveness of such registration statement, and furnish to the selling Investors such numbers of copies of a prospectus, including any supplement to the prospectus, in conformity with the requirements of the Securities Act, and
such other documents as they may reasonably request in order to facilitate the disposition of Covered Securities owned by them. 

(d)    Following the effective date of such registration statement, notify the selling Investors of any request by the
SEC that the Company amend or supplement such registration statement, or the associated prospectus. 
 (e)    Use
commercially reasonable efforts to register and qualify the securities covered by such registration statement under such other securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the selling Investors,
provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of process in any such states or jurisdictions unless the Company is already
qualified to do business or subject to service of process in that jurisdiction. 
 (f)    In the event of any
underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and customary form, with the managing underwriter of such offering. Each selling Investor and other security holder participating in such
underwriting shall also enter into and perform its obligations under such an agreement. 
 (g)    Notify each selling
Investor of Covered Securities covered by such registration statement at any time when a prospectus relating thereto is required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in
such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the
circumstances then existing, such obligation to continue for 120 days or until the distribution described in such registration statement is completed, if earlier. 

(h)    Cause all such Covered Securities registered pursuant to this Section 1 to be listed on each national
securities exchange or trading system on which similar securities issued by the Company are then listed. 

  
 7 

 (i)    Provide a transfer agent and registrar for all Covered
Securities registered pursuant hereunder and a CUSIP number for all such Covered Securities, in each case not later than the effective date of such registration. 

(j)    Make generally available to its security holders, and to deliver to each selling Investor participating in the
registration statement, an earnings statement of the Company that will satisfy the provisions of Section 11(a) of the Securities Act covering a period of 12 months beginning after the effective date of such registration statement as soon as
reasonably practicable after the termination of such 12-month period. 

1.6    Information From Selling Investors. It shall be a condition precedent to the obligations of
the Company to take any action pursuant to this Section 1 with respect to the Covered Securities of any selling Investor that such selling Investor shall furnish to the Company such information regarding such selling Investor, the Covered
Securities held by it, and the intended method of disposition of such securities as shall be required to effect the registration of such Covered Securities. The Company shall have no obligation with respect to any registration requested pursuant to
Section 1.2 or Section 1.4 of this Agreement if, as a result of the application of the preceding sentence, the anticipated aggregate offering price of the Covered Securities to be included in the registration does not equal or exceed the
anticipated aggregate offering price required to originally trigger the Company’s obligation to initiate such registration as specified in subsection 1.2(a) or subsection 1.4(b)(2), whichever is applicable. 

1.7    Expenses of Registration. All expenses other than underwriting discounts and commissions
incurred in connection with registrations, filings or qualifications pursuant to Sections 1.2, 1.3 and 1.4 including (without limitation) all registration, filing and qualification fees, printers’ and accounting fees, fees and
disbursements of counsel for the Company, and the reasonable fees and disbursements of up to a maximum of $50,000 for one counsel for the selling Investors selected by them with the approval of the Company, which approval shall not be
unreasonably withheld, conditioned or delayed, shall be borne by the Company. 
 1.8    Underwriting
Requirements. In connection with any offering involving an underwriting of shares of the Company’s capital stock, the Company shall not be required under Section 1.3 to include any of the selling Investors’ securities in such
underwriting unless they accept the terms of the underwriting as agreed upon between the Company and the underwriters selected by the Company (or by other persons entitled to select the underwriters), and then only in such quantity as the
underwriters determine in their sole discretion will not jeopardize the success of the offering by the Company. If the total amount of securities, including Covered Securities, requested by stockholders to be included in such offering exceeds the
amount of securities sold other than by the Company that the underwriters determine in their sole discretion is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such
securities, including Covered Securities, which the underwriters determine in their sole discretion will not jeopardize the success of the offering (the securities so included to be apportioned pro rata among the selling stockholders according to
the total amount of securities entitled to be included therein owned by each selling stockholder or in such other proportions as shall mutually be agreed to by such selling stockholders) but in no event shall the amount of securities of the selling
Investors included in the offering be reduced to below 30% of the total amount of securities included in such offering. For purposes of the 

  
 8 

 
preceding parenthetical concerning apportionment, for any selling stockholder which is a holder of Covered Securities and which is a venture capital fund, or a partnership or corporation, the
Affiliated Funds, partners, retired partners and stockholders of such holder, or the estates and family members of any such partners and retired partners and any trusts for the benefit of any of the foregoing persons shall be deemed to be a single
“selling stockholder,” and any pro-rata reduction with respect to such “selling stockholder” shall be based upon the aggregate amount of shares carrying registration rights owned by
all entities and individuals included in such “selling stockholder,” as defined in this sentence. Notwithstanding the foregoing, in no event shall any Covered Securities be excluded from such offering unless all other stockholders’
securities have first been excluded. 
 1.9    Delay of Registration. No Investor shall have any
right to obtain or seek an injunction restraining or otherwise delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 1. 

1.10    Indemnification. In the event any Covered Securities are included in a registration statement
under this Section 1: 
 (a)    To the extent permitted by law, the Company will indemnify and hold harmless each
selling Investor, any underwriter (as defined in the Securities Act) for such selling Investor and each person, if any, who controls such selling Investor or underwriter within the meaning of the Securities Act or the Exchange Act, against any
losses, claims, damages, or liabilities (joint or several) to which they may become subject under the Securities Act, the Exchange Act or other federal or state law, insofar as such losses, claims, damages, or liabilities (or actions in respect
thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a “Violation”): (i) any untrue statement or alleged untrue statement of a material fact contained in such
registration statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto, (ii) the omission or alleged omission to state therein a material fact required to be stated therein,
or necessary to make the statements therein not misleading, or (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any state securities law or any rule or regulation promulgated under the Securities
Act, the Exchange Act or any state securities law; and the Company will pay to each such selling Investor, underwriter or controlling person, as incurred, any legal or other expenses reasonably incurred by them in connection with investigating or
defending any such loss, claim, damage, liability, or action; provided, however, that the indemnity agreement contained in this subsection 1.10(a) shall not apply to amounts paid in settlement of any such loss, claim, damage,
liability, or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable to any selling Investor, underwriter or controlling person for any such loss,
claim, damage, liability, or action to the extent that it arises out of or is based upon a Violation which occurs in reliance upon and in conformity with written information furnished expressly for use in connection with such registration by any
such selling Investor, underwriter or controlling person. 
 (b)    To the extent permitted by law, each selling
Investor will indemnify and hold harmless the Company, each of its directors, each of its officers who has signed the registration statement, each person, if any, who controls the Company within the 

  
 9 

 
meaning of the Securities Act, any underwriter, any other Investor selling securities in such registration statement and any controlling person of any such underwriter or other Investor, against
any losses, claims, damages, or liabilities (joint or several) to which any of the foregoing persons may become subject, under the Securities Act, the Exchange Act or other federal or state law, insofar as such losses, claims, damages, or
liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such
Investor expressly for use in connection with such registration; and each such Investor will pay, as incurred, any legal or other expenses reasonably incurred by any person intended to be indemnified pursuant to this subsection 1.10(b), in
connection with investigating or defending any such loss, claim, damage, liability, or action; provided, however, that the indemnity agreement contained in this subsection 1.10(b) shall not apply to amounts paid in settlement of
any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Investor, which consent shall not be unreasonably withheld; provided, that in no event shall any indemnity under this
subsection 1.10(b) exceed the net proceeds from the offering received by such Investor, except in the case of willful fraud by such Investor. 

(c)    Promptly after receipt by an indemnified party under this Section 1.10 of notice of the commencement of any
action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 1.10, deliver to the indemnifying party a written notice of the commencement
thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually
satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties which may be represented without conflict by one counsel) shall have the right to retain one separate counsel, with
the reasonable fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such
indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if prejudicial to its ability to
defend such action, shall relieve such indemnifying party of any liability to the indemnified party under this Section 1.10, but the omission so to deliver written notice to the indemnifying party will not relieve it of any liability that it
may have to any indemnified party otherwise than under this Section 1.10. 
 (d)    If the indemnification
provided for in this Section 1.10 is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to therein, then the indemnifying party, in lieu of
indemnifying such indemnified party hereunder, shall contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage, or expense in such proportion as is appropriate to reflect the relative fault
of the indemnifying party on the one hand and of the indemnified party on the other in connection with the statements or omissions that resulted in such loss, liability, claim, damage or expense as well as any other relevant equitable
considerations; provided, that in no event shall any contribution by a selling Investor under this Subsection 1.10(d) when combined with any amounts paid by such selling Investor pursuant to Subsection 1.10(b) exceed the net proceeds from the
offering received by such selling Investor, 

  
 10 

 
except in the case of willful fraud by such selling Investor. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative
intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission. 

(e)    Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in
the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 

(f)    The obligations of the Company and Investors under this Section 1.10 shall survive the completion of any
offering of Covered Securities in a registration statement under this Section 1, and otherwise. 

1.11    Reports Under the Exchange Act. With a view to making available to the Investors the benefits
of Rule 144 promulgated under the Securities Act and any other rule or regulation of the SEC that may at any time permit an Investor to sell securities of the Company to the public without registration or pursuant to a registration on Form S-3, the Company agrees to: 
 (a)    make and keep public information
available, as those terms are understood and defined in SEC Rule 144, at all times after 90 days after the effective date of the initial public offering of the Company so long as the Company remains subject to the periodic reporting
requirements under Sections 13 or 15(d) of the Exchange Act; 
 (b)    take such action, including the voluntary
registration of its Common Stock under Section 12 of the Exchange Act, as is necessary to enable the Investors to utilize Form S-3 for the sale of their Covered Securities, such action to be taken as
soon as practicable after the end of the fiscal year in which the first registration statement filed by the Company for the offering of its securities to the general public is declared effective; 

(c)    file with the SEC in a timely manner all reports and other documents required of the Company under the Securities
Act and the Exchange Act; and 
 (d)    furnish to any Investor upon request, so long as the Investor owns any Covered
Securities, (i) a written statement by the Company that it has complied with the reporting requirements of SEC Rule 144 (at any time after 90 days after the effective date of the initial public offering of the Company), the Securities Act
and the Exchange Act (at any time after it has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time after
it so qualifies), (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested in availing any
Investor of any rule or regulation of the SEC which permits the selling of any such securities without registration or pursuant to such form. 

  
 11 

 1.12    Assignment of Registration Rights. The
rights to cause the Company to register Covered Securities pursuant to this Section 1 may be assigned (but only with all related obligations) by an Investor to a transferee or assignee (i) of at least 50,000 shares of such securities
(subject to adjustment for stock splits, stock dividends, reclassification or the like) (or if the transferring Investor owns less than 50,000 shares of such securities, then all Covered Securities held by the transferring Investor), (ii) that is a
subsidiary, parent, partner, limited partner, retired partner, member, retired member or stockholder of an Investor, (iii) that is an Affiliated Fund, (iv) who is an Investor’s child, stepchild, grandchild, parent, stepparent,
grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law,
brother-in-law, or sister-in-law (such a relation, an Investor’s “Immediate
Family Member”, which term shall include adoptive relationships), or (v) that is a trust for the benefit of an individual Investor or such Investor’s Immediate Family Member, provided the Company is, within a reasonable
time after such transfer, furnished with written notice of the name and address of such transferee or assignee and the securities with respect to which such registration rights are being assigned; and provided, further, that such
assignment shall be effective only if the transferee agrees in writing to be bound by this Agreement and immediately following such transfer the further disposition of such securities by the transferee or assignee is restricted under the Securities
Act. For the purposes of determining the number of shares of Covered Securities held by a transferee or assignee, the holdings of transferees and assignees of (x) a partnership who are partners or retired partners of such partnership or
(y) a limited liability company who are members or retired members of such limited liability company (including Immediate Family Members of such partners or members who acquire Covered Securities by gift, will or intestate succession) shall be
aggregated together and with the partnership or limited liability company; provided that all assignees and transferees who would not qualify individually for assignment of registration rights shall have a single attorney-in-fact for the purpose of exercising any rights, receiving notices or taking any action under Section 1. 

1.13    Limitations on Subsequent Registration Rights. From and after the date of this Agreement, the
Company shall not, without the prior written consent of the Holders of a majority of the outstanding Registrable Securities, enter into any agreement with any holder or prospective holder of any securities of the Company which would allow such
holder or prospective holder (a) to include any of such securities in any registration filed under Sections 1.2, 1.3 or 1.4 hereof, unless under the terms of such agreement, such holder or prospective holder may include such securities in
any such registration only to the extent that the inclusion of his securities will not reduce the amount of the Registrable Securities of the Holders which is included or (b) to make a demand registration which could result in such registration
statement being declared effective prior to the earlier of either of the dates set forth in subsection 1.2(a) or within 120 days of the effective date of any registration effected pursuant to Section 1.2. 

1.14    Lock-Up Agreement. 

(a)    Lock-Up Period; Agreement. Each Investor hereby agrees that it will
not, without the prior written consent of the managing underwriter, during the period commencing on the date of the final prospectus relating to the Company’s initial public offering and ending on the date specified by the Company and the
managing underwriter (such period not to exceed one hundred eighty (l80) days), or such other period as may be requested by the 

  
 12 

 
Company or an underwriter to accommodate regulatory restrictions on (1) the publication or other distribution of research reports; and (2) analyst recommendations and opinions,
including, but not limited to, the restrictions contained in NYSE Rule 472(f)(4), or any successor provisions or amendments thereto), (a) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any
option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock held immediately prior to the effectiveness of the registration statement for such
initial public offering; or (b) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the capital stock, whether any such transaction described in
clause (a) or (b) above is to be settled by delivery of capital stock or other securities, in cash or otherwise. Each Investor further agrees to execute such agreements as may be reasonably requested by the underwriters in the
Company’s initial public offering that are consistent with this Section 1.14 or that are necessary to give further effect thereto. 

(b)    Limitations. The obligations described in Section 1.14(a) shall apply only if all officers and
directors of the Company, and all holders of greater than 1% of the Company’s capital stock on an as-converted fully diluted basis, enter into similar agreements and shall not apply to a registration
relating solely to employee benefit plans or to a registration relating solely to a transaction pursuant to Rule 145 under the Securities Act. 

(c)    Stop-Transfer Instructions. In order to enforce the foregoing covenants, the Company may impose
stop-transfer instructions with respect to the securities of each Investor (and the securities of every other person subject to the restrictions in Section 1.14(a)). 

(d)    Transferees Bound. Each Investor agrees that prior to the Company’s initial public offering it will
not transfer securities of the Company unless each transferee agrees in writing to be bound by all of the provisions of this Section 1.14, provided that this Section 1.14(d) shall not apply to transfers pursuant to a registration
statement. 
 (e)    Legend. Each Investor agrees that a legend reading substantially as follows shall be placed
on all certificates representing all Covered Securities of each Investor (and the shares or securities of every other person subject to the restriction contained in this Section 1.14): 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD OF UP TO 180 DAYS AFTER
THE EFFECTIVE DATE OF THE ISSUER’S REGISTRATION STATEMENT FILED UNDER THE ACT, AS AMENDED, AS SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE ORIGINAL HOLDER OF THESE SECURITIES, A COPY OF WHICH MAY BE OBTAINED AT THE ISSUER’S
PRINCIPAL OFFICE. SUCH LOCK-UP PERIOD IS BINDING ON TRANSFEREES OF THESE SHARES. 

1.15    Termination of Registration Rights. No Holder shall be entitled to exercise any right provided for
in this Section 1 after the earlier of (i) three (3) years following the 

  
 13 

 
consummation of the initial public offering of the Company, (ii) such time, on or after the initial public offering of the Company, as Rule 144 or another similar exemption under the
Securities Act is available for the sale of all of such Holder’s shares during a ninety-day period without registration, (iii) upon a Liquidation Transaction (as defined in the Restated Certificate),
or (iv) upon termination of this Agreement, as provided in Section 3.1. 
 2.    Covenants
of the Company. 
 2.1    Financial Information. The Company will furnish the following reports to
each Major Investor: 
 (a)    As soon as practicable after the end of each fiscal year of the Company, and in any
event within one hundred eighty (180) days after the end of each fiscal year of the Company, a consolidated balance sheet of the Company and its subsidiaries, if any, as at the end of such fiscal year, and consolidated statements of income and
cash flows of the Company and its subsidiaries, if any, for such year, in each case prepared in accordance with U.S. generally accepted accounting principles, and audited and certified by a nationally recognized public accounting firm selected by
the Company and reasonably acceptable to the Investors. 
 (b)    As soon as practicable after the end of the first,
second and third quarterly accounting periods in each fiscal year of the Company, and in any event within sixty (60) days after the end of the first, second, and third quarterly accounting periods in each fiscal year of the Company, an
unaudited consolidated balance sheet of the Company and its subsidiaries, if any, as of the end of each such quarterly period, and unaudited consolidated statements of income and cash flows of the Company and its subsidiaries, if any, for such
period. 
 (c)    Within 30 days after the end of each month, an unaudited income statement and statement of cash flows
and balance sheet for and as of the end of such month, in reasonable detail. 
 (d)    As soon as practical, but in any
event prior to 60 days before the end of each fiscal year, a budget and business plan for the next fiscal year, prepared on a monthly basis, and, if and when distributed to the Company’s Board of Directors, any other updated or revised budgets
for such fiscal year prepared by or for the Company. 
 2.2    Right of First Offer. Subject to the terms
and conditions specified in this Section 2.2, the Company hereby grants to each Major Investor a right of first offer with respect to future sales by the Company of its Shares (as hereinafter defined). For purposes of this Section 2.2,
Major Investor includes any general partners, managing members and affiliates of a Major Investor, including Affiliated Funds. A Major Investor who chooses to exercise the right of first offer may designate as purchasers under such right itself or
its partners or affiliates, including Affiliated Funds, in such proportions as it deems appropriate. 
 Each time the Company proposes to
offer any shares of, or securities convertible into or exercisable for any shares of, any class of its capital stock (“Shares”), the Company shall first make an offering of such Shares to each Major Investor in accordance with the
following provisions: 

  
 14 

 (a)    The Company shall deliver a notice (the “RFO
Notice”) to the Major Investors stating (i) its bona fide intention to offer such Shares, (ii) the number of such Shares to be offered, and (iii) the price and terms, if any, upon which it proposes to offer such Shares. 

(b)    Within 30 days after delivery of the RFO Notice, the Major Investor may elect to purchase or obtain, at the price
and on the terms specified in the RFO Notice, up to that portion of such Shares which equals the proportion that the number of shares of Common Stock issued and held, or issuable upon conversion and exercise of all convertible or exercisable
securities then held, by such Major Investor bears to the total number of shares of Common Stock then outstanding (assuming full conversion and exercise of all outstanding convertible or exercisable securities, rights, options and warrants).
Such purchase shall be completed at the same closing as that of any third party purchasers or at an additional closing. The Company shall promptly, in writing, inform each Major Investor that elects to purchase all the shares available to it (each,
a “Fully-Exercising Investor”) of any other Major Investor’s failure to do likewise. During the 10-day period commencing after receipt of
such information, each Fully-Exercising Investor shall be entitled to obtain that portion of the Shares for which Major Investors were entitled to subscribe but which were not subscribed for by the Major
Investors that is equal to the proportion that the number of shares of Common Stock issued and held, or issuable upon conversion and exercise of all convertible or exercisable securities then held, by such Fully-Exercising Investor bears to the
total number of shares of Common Stock then outstanding (assuming conversion of all outstanding shares of Preferred Stock). 

(c)    The Company may, during the 45-day period following the expiration of the
period provided in subsection 2.3(b) hereof, offer the remaining unsubscribed portion of the Shares to any person or persons at a price not less than, and upon terms no more favorable to the offeree than those specified in the RFO Notice. If
the Company does not enter into an agreement for the sale of the Shares within such period, or if such agreement is not consummated within 60 days after the execution thereof, the right provided hereunder shall be deemed to be revived and such
Shares shall not be offered unless first reoffered to the Major Investors in accordance herewith. 
 (d)    The right
of first offer in this Section 2.3 shall not be applicable to (i) the issuance of securities in connection with stock dividends, stock splits or similar transactions; (ii) the issuance or sale of Common Stock (or options
therefor) to employees, officers, consultants or directors of the Company, or other persons performing services for the Company, directly or pursuant to a stock option plan or restricted stock plan approved by the Board of Directors; (iii) the
issuance of securities pursuant to the conversion or exercise of convertible or exercisable securities outstanding as of the date of this Agreement, including without limitation, warrants, notes or options, or issued pursuant to the Purchase
Agreement; (iv) the issuance or sale of the Series C Preferred Stock pursuant to the Purchase Agreement; or (v) the issuance of securities in connection with the Company’s (1) acquisition of intellectual property,
(2) entering into a strategic partnership transaction primarily for a purpose other than raising capital, (3) acquisition of real property or personal property leases, (4) acquisition of marketing rights, or (5) equipment
financing or other debt financings, and (vi) securities of the Company which are otherwise excluded from the right of first offer by the affirmative vote or consent of the holders of at least a majority of the shares of Preferred Stock of the
Company then 

  
 15 

 
outstanding, voting together as a single class on an as-converted basis. In addition to the foregoing, the right of first offer in this Section 2.3
shall not be applicable with respect to any Investor and any subsequent securities issuance, if (i) at the time of such subsequent securities issuance, the Major Investor is not an “accredited investor,” as that term is then defined
in Rule 501(a) under the Securities Act, and (ii) such subsequent securities issuance is otherwise being offered only to accredited investors. 

2.3    Board Voting. So long as RTW is entitled to appoint the RTW Director (as defined in the Voting
Agreement) pursuant to the terms of the Amended and Restated Voting Agreement of even date herewith (the “Voting Agreement”), if ever,, the Company shall not, without approval of the Board of Directors, including the affirmative
vote of the RTW Director: 
 (a)    make any loan or advance to, or own any stock or other securities of, any
subsidiary or other corporation, partnership, or other entity unless it is wholly owned by the Company; 
 (b)    make
any loan or advance to any person, including, any employee or director, except advances and similar expenditures in the ordinary course of business or under the terms of an employee stock or option plan approved by the Board of Directors; 

(c)    guarantee any indebtedness except for trade accounts of the Company or any subsidiary arising in the ordinary
course of business; 
 (d)    make any investment inconsistent with any investment policy approved by the Board; 

(e)    incur any aggregate indebtedness in excess of $1.5 million that is not already included in a budget approved
by the Board of Directors, other than trade credit incurred in the ordinary course of business; 
 (f) enter into or be a party to any
transaction with any director, officer or employee of the Company or any “associate” (as defined in Rule 12b-2 promulgated under the Exchange Act) of any such person except transactions resulting in
payments to or by the Company in an amount less than $60,000 per year, or transactions made in the ordinary course of business and pursuant to reasonable requirements of the Company’s business and upon fair and reasonable terms that are
approved by a majority of the Board of Directors; 
 (g)    hire, fire, or change the compensation of the executive
officers, including approving any option grants except upon fair and reasonable terms that are approved by a majority of the Board of Directors; 

(h)    change the principal business of the Company, enter new lines of business, or exit the current line of business;

 (i)    sell, assign, license, pledge or encumber material technology or intellectual property, other than licenses
granted in the ordinary course of business; or 

  
 16 

 (j)    enter into any corporate strategic relationship involving the
payment contribution or assignment by the Company or to the Company of assets greater than $100,000. 

2.4    Termination of Covenants. 

(a)    The covenants set forth in Sections 2.1 and 2.2 shall terminate as to each Investor and be of no further
force or effect (i) immediately prior to the consummation of an initial public offering, or (ii) upon termination of the Agreement, as provided in Section 3.1. 

(b)    The covenants set forth in Section 2.1 shall terminate as to each Investor and be of no further force or
effect when the Company first becomes subject to the periodic reporting requirements of Sections 13 or 15(d) of the Exchange Act, if this occurs earlier than the events described in Section 2.7(a) above. 

3.    Miscellaneous. 

3.1    Termination. This Agreement shall terminate, and have no further force and effect, when the Company
shall consummate a Liquidation Transaction as defined in the Restated Certificate. 
 3.2    Entire
Agreement. This Agreement constitutes the entire agreement between the parties hereto pertaining to the subject matter hereof, and any and all other written or oral agreements relating to the subject matter hereof existing between the parties
hereto are expressly canceled. This Agreement supersedes and replaces in its entirety the Prior Agreement. 

3.3    Successors and Assigns. Except as otherwise provided in this Agreement, the terms and conditions of
this Agreement shall inure to the benefit of and be binding upon the respective permitted successors and assigns of the parties (including transferees of any of the Preferred Stock or any Common Stock issued upon conversion thereof). Nothing in this
Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly
provided in this Agreement. Notwithstanding anything herein to the contrary, the rights under this Agreement may be assigned by an Investor only to an Affiliated Fund that is not a competitor to the Company; provided that (1) such transfer or
assignment of Registrable Securities is effected in accordance with the terms of this Agreement, and applicable securities laws, (2) the Company is given written notice prior to said transfer or assignment, stating the name and address of the
transferee or assignee and identifying the securities with respect to which such registration rights are intended to be transferred or assigned and (3) the transferee or assignee of such rights assumes in writing the obligations of such Holder
under this Agreement, including without limitation the obligations set forth in Section 1.4. 

3.4    Amendments and Waivers. Any term of this Agreement may be amended or waived only with the written
consent of the Company and the holders of at least 70% of the Registrable Securities then outstanding; provided, however, that any amendment or waiver that adversely affects the rights granted the Common Holders must be approved by the
holders of a majority of the Common Stock then outstanding, and provided, further, that any amendment or 

  
 17 

 
waiver of the rights granted to the Major Investors in Section 2 above shall require the consent of a majority in interest of the Covered Securities held by the Major Investors, and provided
further that any amendment to the last sentence of Section 1.1(g) above shall require the consent of RTW. Notwithstanding the foregoing, this Agreement may be amended with only the written consent of the Company for the sole purpose of
including additional purchasers of Series C Preferred Stock as “Investors” and “Holders.” Any amendment or waiver effected in accordance with this paragraph shall be binding upon each party to the Agreement, whether or not such
party has signed such amendment or waiver, each future holder of all such Registrable Securities, and the Company. 

3.5    Notices. All notices and other communications given or made pursuant to this Agreement shall be in
writing and shall be deemed effectively given upon the earlier of actual receipt or (a) personal delivery to the party to be notified, (b) when sent, if sent by electronic mail or facsimile during normal business hours of the recipient,
and if not sent during normal business hours, then on the recipient’s next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) business day
after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with written verification of receipt. All communications shall be sent to the respective parties at their address on the signature
page or Exhibit A hereof (or if no address has been provided the last known address of such parties as reflected in the Company’s record), as the case may be, or to such email address, facsimile number or address as subsequently modified by
written notice given in accordance with this Section 6.4. If notice is given to the Company, it shall be sent to 11099 No. Torrey Pines Rd., Suite 100, La Jolla, CA 92037, Attention: Chief Executive Officer; and a
copy (which shall not constitute notice) shall also be sent to Wilson Sonsini Goodrich & Rosati, 12235 El Camino Real, Suite 200, San Diego, CA 92130, Attention: Martin Waters; and if notice is given to the Investors, a copy shall also be
given to John Crandon, Esq., 36 Grattan Street, San Francisco, CA 94117.. 
 3.6    Severability. If one
or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall be excluded from this Agreement, and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be
enforceable in accordance with its terms. 
 3.7    Governing Law. This Agreement and all acts and
transactions pursuant hereto shall be governed, construed and interpreted in accordance with the laws of the State of Delaware, without giving effect to principles of conflicts of laws. 

3.8    Counterparts. This Agreement may be executed in two or more counterparts, each of which shall
be deemed an original, but all of which together shall constitute one and the same instrument. 

3.9    Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience
only and are not to be considered in construing or interpreting this Agreement. 
 3.10    Aggregation of
Stock. All shares of the Preferred Stock or Common Stock held or acquired by affiliated entities or persons shall be aggregated together for the purpose of 

  
 18 

 
determining the availability of any rights under this Agreement and such Affiliated persons may apportion such rights as among themselves in any manner they deem appropriate 

3.11    Termination of Prior Rights Agreement. The Prior Rights Agreement is hereby terminated and shall
have no further force or effect. 
 [Signature Pages Follow] 

  
 19 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

			
	COMPANY:
	
	DERMTECH, INC.
		
	By:	 	/s/ John Dobak
	Name: John Dobak
	Title: President and CEO

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

			
	INVESTORS:
	
	RTW MASTER FUND, LTD
		
	By:	 	 /s/ Roderick Wong

	Name: Roderick Wong
	Title: Director
	
	RTW INNOVATION MASTER FUND, LTD
		
	By:	 	 /s/ Roderick Wong

	Name: Roderick Wong
	Title: Director

 [INVESTOR SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

			
	NEW INVESTORS:
	
	Paulson DermTech Investments III LLC
		
	By:	 	 /s/ Starla Goff

	Name: Starla Goff
	Title: Officer of the Managing Member

 [INVESTOR SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

			
	NEW INVESTORS:
	
	Paulson DermTech Investments II LLC
		
	By:	 	 /s/ Starla Goff

	Name: Starla Goff
	Title: Officer of the Managing Member

 [INVESTOR SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

			
	NEW INVESTORS:
	
	Paulson DermTech Investments LLC
		
	By:	 	 /s/ Starla Goff

	Name: Starla Goff
	Title: Officer of the Managing Member

 [INVESTOR SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

			
	NEW INVESTORS:
	
	Irwin and Joan Jacobs Family Trust 6-2-80
		
	By:	 	 /s/ Irwin M. Jacobs

	Name: Irwin M. Jacobs
	Title: Trustee

 [INVESTOR SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

	
	NEW INVESTORS:
	
	/s/ Dana Donovan
	Dana Donovan

 [INVESTOR SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

			
	NEW INVESTORS:
	
	Roberta Feuerstein Trust DTD 7-9-83
		
	By:	 	 /s/ Roberta Feuerstein

	Name: Roberta Feuerstein Trust DTD 7-9-83
	Title: Trustee

 [INVESTOR SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

	
	NEW INVESTORS:
	
	/s/ Patrick E. Pellecchia
	Patrick E. Pellecchia

 [INVESTOR SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

			
	NEW INVESTORS:
	
	Pacific Equity Ventures, L.P., a California limited partnership
		
	By:	 	 /s/ Andrew M. Kaplan

	Name: Andrew M. Kaplan
	Title: CEO of GP

 [INVESTOR SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

	
	NEW INVESTORS:
	
	/s/ Gene Salkind, M.D.
	Gene Salkind, M.D.

 [INVESTOR SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

			
	NEW INVESTORS:
	
	 /s/ Gary E. Jacobs

	Gary Jacobs
	
	Jacobs Investment Company LLC
		
	By:	 	 /s/ Gary E. Jacobs

	Name: Gary E. Jacobs
	Title: Managing Member
	
	Gary E and Jerri-Anne Jacobs Trustees
		
	By:	 	 /s/ Gary E. Jacobs

	Name: Gary E. Jacobs
	Title: Trustee

 [INVESTOR SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

			
	NEW INVESTORS:
	
	 /s/ Elliot Feuerstein

	Elliot Feuerstein
	
	Brett Feuerstein Children’s Trust
		
	By:	 	 /s/ Elliot Feuerstein

	Name: Elliot Feuerstein
	Title: Trustee
	
	Michael Feuerstein Children’s Trust
		
	By:	 	 /s/ Elliot Feuerstein

	Name: Elliot Feuerstein
	Title: Trustee
	
	Elliot Feuerstein Trust DTD 5-14-83
		
	By:	 	 /s/ Elliot Feuerstein

	Name: Elliot Feuerstein
	Title: Trustee
	
	Mesa Shopping Center East LLC
		
	By:	 	 /s/ Elliot Feuerstein

	Name: Elliot Feuerstein
	Title: Manager
	
	Mesa Shopping Center East LLC
		
	By:	 	 /s/ Elliot Feuerstein

	Name: Elliot Feuerstein
	Title: Manager
	
	Mira Mesa Shopping Center West LLC
		
	By:	 	 /s/ Elliot Feuerstein

	Name: Elliot Feuerstein
	Title: Manager
	
	Mira Mesa Shopping Center LLC
		
	By:	 	 /s/ Elliot Feuerstein

	Name: Elliot Feuerstein
	Title: Manager

 [INVESTOR SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

	
	NEW INVESTORS:
	
	/s/ Gregory A. Erickson
	Gregory A. Erickson

 [INVESTOR SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

			
	NEW INVESTORS:
	
	Touchstone Investments Defined Benefit Plan Pension Trust
		
	By:	 	 /s/ Gregory A. Erickson

	Name: Gregory A. Erickson
	Title: Trustee

 [INVESTOR SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

	
	NEW INVESTORS:
	
	/s/ John Dobak
	John Dobak

 [INVESTOR SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

	
	NEW INVESTORS:
	
	/s/ Jeremy and Junko Teraoka
	Jeremy and Junko Teraoka

 [INVESTOR SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of
the date set forth below. 
  

			
	NEW INVESTORS:
	
	Darakev LP
		
	By:	 	 /s/ Kevin Wechter

	Name: Kevin Wechter
	Title: CEO of Darakev Management LLC its GP

 [INVESTOR SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 EXHIBIT A-1 

INVESTORS 
 COMMON HOLDERS: 

 

	
	 Name

	The Jacobs Investment Company LLC
	Gene Salkind, M.D.
	Peter Brundage
	Elliot Feuerstein, Trustee for Elliot Feuerstein Trust UTD 5-14-82
	Elliot Feuerstein, Trustee FBO Michael Feuerstein, Feuerstein Children’s Trust UTD 3-15-89
	Elliot Feuerstein, Trustee FBO Brett Feuerstein, Feuerstein Children’s Trust UTD 3-15-89

 EXHIBIT A-2 

INVESTORS 
 EXISTING INVESTORS:

  

	
	 Name

	The Jacobs Investment Company LLC
	Gary Jacobs
	Peter Brundage
	Gene Salkind, M.D.
	KT4 Partners LLC
	Dennis Logue
	Frederick McCarthy
	Elliott Feuerstein
	Elliot Feuerstein, Trustee FBO Michael Feuerstein, Feuerstein Children’s Trust UTD 3-15-89
	Elliot Feuerstein, Trustee FBO Brett Feuerstein, Feuerstein Children’s Trust UTD 3-15-89
	Daniel Einhorn and Emily Feldman Einhorn Trust of 1994
	Patrick E. Pellecchia
	Gregory A. Erickson
	Touchstone Investments Defined Benefit Plan Pension Trust: Gregory A. Erickson, Trustee
	Elliot Feuerstein, Trustee for Elliot Feuerstein Trust UTD 5-14-82
	Darakev LP, a Texas limited partnership
	John Dobak
	Pacific Equity Ventures, L.P., a California limited partnership
	Chitayat Family Gift Trust dated 12/19/2003
	DLA Piper
	WS Investment Company, LLC (2013A)
	Adams Family Trust, UAD 6-34-94
	Dana Donovon
	Harmon Spolan
	Jack L. Stahl
	Jill M. Olson
	Likipi Holding SA
	Michael Sanders Stotsky Trust
	Steven M. Wetzner
	Leon Wagner
	Ian Katz

 EXHIBIT A-3 

INVESTORS 
 PREFERRED HOLDERS: 

 

	
	 Name

	Irwin and Joan Jacobs Family Trust 6-2-80
	Gregory A. Erickson
	Pacific Equity Ventures LP
	William C. Skelsey & Maral K. Skelsey JTROS
	Paulson DermTech Investment III, LLC
	Mira Mesa Shopping Center LLC
	Mira Mesa Shopping Center, -West, LLC
	Mesa Shopping Center, - East, LLC
	Elliot Feuerstein Trust DTD 5-14-83
	Roberta Feuerstein Trust DTD 7-9-83
	Darakev, L.P.
	Jeremy and Junko Teraoka
	RTW Master Fund, LTD
	RTW Innovation Master Fund, LTD

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}]]